{
  "trial_id": "NCT04676646",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Adults aged \u226518 years",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Potassium and estimated glomerular filtration rate (eGFR)",
      "label": "unknown",
      "evidence": "unknown"
    },
    {
      "criterion": "Cohort 1: sK+ 5.1-5.9 mEq/L at screening/study enrolment and eGFR \u226530 mL/min/1.73 m2;",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Cohort 2: Normokalaemic (sK+ 3.5-5.0 mEq/L) at screening and 'at risk' of developing HK defined as either:",
      "label": "unknown",
      "evidence": "unknown"
    },
    {
      "criterion": "Have a history of HK (sK+ >5.0 mEq/L) within the prior 24 months and eGFR \u226530 mL/min/1.73 m2, or",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "sK+ \u22654.5 mEq/L and eGFR 30 to 60 mL/min/1.73 m2 and/or age >75 years",
      "label": "unknown",
      "evidence": "unknown"
    },
    {
      "criterion": "Symptomatic HFrEF (New York Heart Association [NYHA] class II-IV), which has been present for at least 3 months",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Left ventricular ejection fraction (LVEF) \u226440%",
      "label": "unknown",
      "evidence": "unknown"
    },
    {
      "criterion": "Receiving angiotensin-converting enzyme inhibitor (ACEi), angiotensin II receptor blocker (ARB), or angiotensin receptor-Neprilysin inhibitor (ARNi) (stable dose for \u22654 weeks)",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Not on spironolactone or eplerenone, or on low-dose spironolactone (<25 mg daily).",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Receiving beta-blocker (stable dose for \u22654 weeks) unless contraindicated.",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "constrictive pericarditis, hypertrophic (obstructive) cardiomyopathy, or severe stenotic valve disease as a primary cause of HF",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Current inpatient hospitalisation due to HF",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Previous cardiac transplantation or implantation of a ventricular assistance device (VAD) or similar device, or transplantation or implantation expected after randomisation",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient is a 3-day-old female infant with jaundice that started one day ago. She was born at 34w of gestation and kept in an incubator due to her gestational age.",
  "_meta": {
    "topic_id": "73",
    "trial_id": "NCT04676646",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}